Global Vascular Injury Treatment Market (2020 to 2025) - Growth, Trends, and Forecasts - ResearchAndMarkets.com

The "Vascular Injury Treatment Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.

The rising occurrences of vascular casualties are amongst the critical factors in the development of the worldwide market for vascular injury treatment.

Companies Mentioned

• Cleveland Clinic
• Massachusetts General Hospital
• Heidelberg University Hospital
• Royal Berkshire NHS Foundation Trust
• Mayo Clinic Health System
• Tenet Healthcare
• Apollo Hospitals Enterprise Ltd.
• Universal Health Services, Inc.
• Mediclinic International
• CHSPSC, LLC

Key Market Trends

Bypass Graft segment is Expected to Hold the Largest Market Share in the Vascular Injury Treatment Market

The dominant share is retained by the bypass graft segment owing to the attributes such as high incidence rates and health complications associated with vascular diseases. Stroke, arteriovenous malformation (AVM), peripheral artery disease (PAD), carotid artery disease (CAD), abdominal aortic aneurysm (AAA), pulmonary embolism, critical limb ischemia (CLI), deep vein thrombosis (DVT), varicose veins, and chronic venous insufficiency (CVI) are the most severe vascular disorders which is also responsible for boosting the market growth during the forecast period.

As per the National Institutes of Health (NIH), about 14 million men and women across the country are affected by coronary heart disease. It is most common in people over 65 years old. The disease is caused by a waxy substance called a plaque that accumulates blood to the heart muscle within the arteries.

Bypass graft is the most common treatment for vascular injury to improve poor blood flow to the heart. This surgery could reduce the risk of severe complications for individuals with obstructive coronary artery disease, a form of heart disease ischemic. Thus, the demand for bypass graft is increasing and will drive the market growth during the forecast period.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to maintain its supremacy in the overall vascular injury treatment market, throughout the forecast period. The increasing prevalence of vascular diseases is the major factor expected to drive the overall growth of the market, during the forecast period. Furthermore, there is a rise in geriatric population in the United States, which is expected to create more opportunities for the peripheral vascular treatment market in the region.

According to the estimates of the Center for Diseases Control and Prevention (CDC), approximately 8.5 million people in the United States suffer from peripheral artery diseases, which includes 12%-20% of individuals older than age 60 are also some of the main factors ensuring the dominance of the region.

Key Topics Covered:

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Rising Incidence of Vascular Injury Surgeries

4.2.2 Advancement in Technologies

4.3 Market Restraints

4.3.1 Side Effects Associated with the Vascular Injury Treatment

4.4 Porter's Five Force Analysis

4.4.1 Threat of New Entrants

4.4.2 Bargaining Power of Buyers/Consumers

4.4.3 Bargaining Power of Suppliers

4.4.4 Threat of Substitute Products

4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

5.1 By Treatment

5.1.1 Patch Angioplasty

5.1.2 Lateral Arteriorrhaphy/ Venorrhaphy

5.1.3 Bypass Graft

5.1.4 Thrombectomy

5.1.5 Extraanatomic Bypass

5.1.6 Others

5.2 By Injury

5.2.1 Thrombosis

5.2.2 Contusion/Intimal Flap

5.2.3 Laceration/Transection

5.2.4 Spasm

5.2.5 Aneurysm and Pseudoaneurysm

5.2.6 Arteriovenous (AV) Fistula

5.2.7 Others

5.3 Geography

5.3.1 North America

5.3.2 Europe

5.3.3 Asia-Pacific

5.3.4 Middle-East and Africa

5.3.5 South America

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit https://www.researchandmarkets.com/r/2emu99

View source version on businesswire.com: https://www.businesswire.com/news/home/20200917005635/en/